TTAB Oppositions 91303572
USPTO Oppositions proceeding 91303572, filed 2025-12-06. Status: Pending.
Proceeding Facts
| Proceeding Number | 91303572 |
|---|---|
| Type | Oppositions |
| Status | Pending |
| Filing Date | 2025-12-06 |
| Last Activity | 2026-04-03 |
| Days Active | 160 |
Parties
- Humacyte Global, Inc. — Defendant
- Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD. — Plaintiff
Plaintiff Marks
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
- TEVA — Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries LTD.
Defendant Marks
- ATEV — Humacyte Global, Inc.
Recent Documents
- 2026-04-03: EXTENSION OF TIME GRANTED — Extensions
- 2026-04-03: D MOT FOR EXT W/ CONSENT — Motions
- 2026-03-05: EXTENSION OF TIME GRANTED — Extensions
- 2026-03-05: D MOT FOR EXT W/ CONSENT — Motions
- 2026-02-03: EXTENSION OF TIME GRANTED — Extensions
- 2026-02-03: D MOT FOR EXT W/ CONSENT — Motions
- 2025-12-06: INSTITUTED — Status
- 2025-12-06: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2025-12-06: FILED AND FEE — Fees